These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 3165053

  • 21. Insulin protects against hepatic bioenergetic deterioration induced by cancer cachexia: an in vivo 31P magnetic resonance spectroscopy study.
    Brauer M, Inculet RI, Bhatnagar G, Marsh GD, Driedger AA, Thompson RT.
    Cancer Res; 1994 Dec 15; 54(24):6383-6. PubMed ID: 7987832
    [Abstract] [Full Text] [Related]

  • 22. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL.
    Cancer; 2007 Sep 15; 110(6):1396-403. PubMed ID: 17674351
    [Abstract] [Full Text] [Related]

  • 23. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Apr 15; 414():1-284. PubMed ID: 12616284
    [Abstract] [Full Text] [Related]

  • 24. [Mechanism and treatment of cancer cachexia in tumor-bearing mice].
    Li T, Li C.
    Zhonghua Zhong Liu Za Zhi; 1997 May 15; 19(3):188-91. PubMed ID: 10920893
    [Abstract] [Full Text] [Related]

  • 25. Gluconeogenesis in the tumor-influenced rat hepatocyte: importance of tumor burden, lactate, insulin, and glucagon.
    Inculet RI, Peacock JL, Gorschboth CM, Norton JA.
    J Natl Cancer Inst; 1987 Nov 15; 79(5):1039-46. PubMed ID: 3316783
    [Abstract] [Full Text] [Related]

  • 26. Cachectin activity in the serum of cachectic, tumor-bearing rats.
    Stovroff MC, Fraker DL, Norton JA.
    Arch Surg; 1989 Jan 15; 124(1):94-9. PubMed ID: 2910253
    [Abstract] [Full Text] [Related]

  • 27. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1987 Jan 15; 319():1-198. PubMed ID: 12748734
    [Abstract] [Full Text] [Related]

  • 28. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P.
    Toxic Rep Ser; 1993 Dec 15; 27():1-D9. PubMed ID: 12209179
    [Abstract] [Full Text] [Related]

  • 29. General 4-week toxicity study with EMS in the rat.
    Pfister T, Eichinger-Chapelon A.
    Toxicol Lett; 2009 Nov 12; 190(3):271-85. PubMed ID: 19442710
    [Abstract] [Full Text] [Related]

  • 30. Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.
    Grunfeld C, Wilking H, Neese R, Gavin LA, Moser AH, Gulli R, Serio MK, Feingold KR.
    Cancer Res; 1989 May 15; 49(10):2554-60. PubMed ID: 2713842
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone administration preserves lean body mass in sarcoma-bearing rats treated with doxorubicin.
    Ng B, Wolf RF, Weksler B, Brennan MF, Burt M.
    Cancer Res; 1993 Nov 15; 53(22):5483-6. PubMed ID: 8221688
    [Abstract] [Full Text] [Related]

  • 32. Relationship between interleukin-1 and cancer anorexia.
    Laviano A, Renvyle T, Meguid MM, Yang ZJ, Cangiano C, Rossi Fanelli F.
    Nutrition; 1995 Nov 15; 11(5 Suppl):680-3. PubMed ID: 8748251
    [Abstract] [Full Text] [Related]

  • 33. Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats.
    Granado M, Priego T, Martín AI, Vara E, López-Calderón A, Angeles Villanúa M.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):204-10. PubMed ID: 16545800
    [Abstract] [Full Text] [Related]

  • 34. Animal models for the study of cancer-induced anorexia.
    Garattini S, Guaitani A.
    Cancer Treat Rep; 1981 Apr 24; 65 Suppl 5():23-35. PubMed ID: 6955017
    [Abstract] [Full Text] [Related]

  • 35. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
    Wang W, Iresjö BM, Karlsson L, Svanberg E.
    Clin Nutr; 2000 Apr 24; 19(2):127-32. PubMed ID: 10867731
    [Abstract] [Full Text] [Related]

  • 36. Correlation between food intake and cerebrospinal fluid interleukin 1 alpha in anorectic tumor-bearing rats.
    Opara EI, Laviano A, Meguid MM.
    Nutrition; 1995 Apr 24; 11(5 Suppl):678-9. PubMed ID: 8748250
    [Abstract] [Full Text] [Related]

  • 37. Mode of food intake reduction in Lewis rats with indomethacin-induced ulcerative ileitis.
    Veerabagu MP, Opara EI, Meguid MM, Nandi J, Oler A, Holtzapple PG, Levine RA.
    Physiol Behav; 1996 Aug 24; 60(2):381-7. PubMed ID: 8840895
    [Abstract] [Full Text] [Related]

  • 38. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1994 Jan 24; 424():1-304. PubMed ID: 12616287
    [Abstract] [Full Text] [Related]

  • 39. Mediation of anorexia by human recombinant tumor necrosis factor through a peripheral action in the rat.
    Bodnar RJ, Pasternak GW, Mann PE, Paul D, Warren R, Donner DB.
    Cancer Res; 1989 Nov 15; 49(22):6280-4. PubMed ID: 2804974
    [Abstract] [Full Text] [Related]

  • 40. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M, Yates AJ, Garrett IR, Chavez J, Dunn JF, Bonewald L, Mundy GR.
    Lab Invest; 1990 Nov 15; 63(5):676-82. PubMed ID: 2232714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.